Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
HUM Transcript
Humana Inc. (HUM) Q4 2025 Earnings Call Transcript
Unknown2-11
The earnings call reveals a mix of positive and cautious elements. The company shows strong financial performance and operational efficiency, with promising plans for cost savings and strategic acquisitions. However, conservative guidance and lack of share repurchase plans for 2025, combined with unclear management responses in the Q&A, temper enthusiasm. The market reaction is expected to be neutral, considering the balance of positive growth initiatives and cautious financial outlook.
Humana Inc. (HUM) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript
Neutral11-19
Humana Inc. (HUM) Q3 2025 Earnings Call Transcript
Positive11-5
The earnings call highlights several positive developments, including a raised EPS outlook, better-than-expected MA membership retention, and successful Medicaid expansion. CenterWell Pharmacy's growth and strategic capital deployment further bolster the outlook. While management avoided specific guidance, optimistic expectations for margin doubling by 2026 and strategic focus on high-value members suggest a positive trajectory. The Q&A section did not reveal significant negative trends, supporting a positive sentiment. Overall, the company's strategic initiatives and financial performance indicate a likely positive stock price movement in the short term.
Humana Inc. (HUM) Q2 2025 Earnings Call Transcript
Positive7-30
The earnings call summary and Q&A indicate positive sentiments overall, with strong financial performance, growth in membership, and strategic investments in AI and operational efficiency. The reaffirmed EPS guidance and CenterWell's outperformance contribute positively. However, concerns about home health rule changes and ongoing litigation slightly temper the outlook. The lack of market cap data limits prediction specificity, but overall sentiment suggests a positive stock price movement in the near term.
HUM Slides
HUM Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
